The trademark application ALTIFLEX was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 17, 2022, and it was registered by office on January 24, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on February 13, 2023.